Relay Thoracic Stent-Graft Clinical Trial -


	Home About TAA Treatment About The Relay Clinical Trial Clinical Trial Sites Helpful Links Medicare Aneurysm Screening Contact

What makes Relay Thoracic Stent-Graft unique

The Relay Thoracic Stent-Graft offers the following:

A wide range of stent diameters ( 22 – 46 mm) and lengths (100, 150, 200, 250 mm) to accommodate a variety of patient anatomies
Straight or tapered devices to accomodate different aortic shapes and configurations
Precise two step system for placing the stent in the aorta
Made of material that does not interfere with MRI procedures

About The Relay Clinical Trial

The Relay Thoracic Stent-Graft is considered experimental in the U.S. However, this device has been approved in Europe since 2005, and it has been used to successfully treat 2500 patients. Please read this information over closely, and discuss any questions you may have with your doctor. Only your doctor can decide if you are a good candidate for the Relay Thoracic Stent-Graft procedure.

How Relay Works

The Relay Thoracic Stent-Graft is implanted in the body using the Transport ® Delivery System. The animation below (no audio) illustrates how Relay Thoracic Stent-Graft is implanted in the aorta.

Who Can Participate in the Relay Thoracic Stent Graft Clinical Trial?

You may be considered for the Relay trial if you are:

Male or Female at least 18 years of age Diagnosed with descending TAA
Have anatomy that can accommodate the Relay Thoracic Stent-Graft
Consent to participate
Agree to comply with the follow-up schedule

You will not be considered for the Relay trial if you:

Have a condition other than an aneurysm in your aorta
Have less than one-year life expectancy
Are pregnant
Have medical conditions that would interfere with the Relay procedure (e.g. Marfan’s Syndrome)
Are participating in other clinical studies

Content on this page requires a newer version of Adobe Flash Player.